The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates

Anaerobe

Volumn 24, Issue , 2013, Pages 109-116

  Carlson, Paul E ^a   Walk, Seth T ^a   Bourgis, Alexandra E T ^a   Liu, Melissa W ^a   Kopliku, Fatos ^a   Lo, Eugene ^a   Young, Vincent B ^a   Aronoff, David M ^a   Hanna, Philip C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Clostridium difficile; NAP1 027; Ribotype; Sporulation

Indexed keywords

CLOSTRIDIUM TOXIN;

ARTICLE; BACTERIAL GROWTH; BACTERIAL SPORE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RIBOTYPE; SPORE GERMINATION; SPOROGENESIS; UNITED STATES; VERO CELL;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE; NAP1/027; RIBOTYPE; SPORULATION;

BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; GENOTYPE; HUMANS; MICHIGAN; PHENOTYPE; RIBOTYPING; SEVERITY OF ILLNESS INDEX; SPORES, BACTERIAL; VIRULENCE;

EID: 84889080458     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.04.003     Document Type: Article

References (27)

1. Kuijper E.J., Coignard B., Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clinical Microbiology and Infection 2006, 12(Suppl. 6):2-18.
2. Dubberke E. Clostridium difficile infection: the scope of the problem. Journal of Hospital Medicine 2012, 7(Suppl. 3):S1-S4.
3. O'Connor J.R., Johnson S., Gerding D.N. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 2009, 136:1913-1924.
4. Akerlund T., Persson I., Unemo M., Noren T., Svenungsson B., Wullt M., et al. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. Journal of Clinical Microbiology 2008, 46:1530-1533.
5. Merrigan M., Venugopal A., Mallozzi M., Roxas B., Viswanathan V.K., Johnson S., et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. Journal of Bacteriology 2010, 192:4904-4911.
6. Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079-1084.
7. Walk S.T., Micic D., Jain R., Lo E.S., Trivedi I., Liu E.W., et al. Clostridium difficile ribotype does not predict severe infection. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55:1661-1668.
8. Burns D.A., Heeg D., Cartman S.T., Minton N.P. Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027. PLoS ONE 2011, 6:e24894.
9. Rao K., Walk S.T., Micic D., Chenoweth E., Deng L., Galecki A.T., et al. Procalcitonin levels associate with severity of Clostridium difficile infection. PLoS ONE 2013, 8:e58265.
10. Sorg J.A., Dineen S.S. Laboratory maintenance of Clostridium difficile. Current Protocols in Microbiology 2009, Chapter 9:Unit9A 1.
11. McDonald L.C., Coignard B., Dubberke E., Song X., Horan T., Kutty P.K. Recommendations for surveillance of Clostridium difficile-associated disease. Infection Control and Hospital Epidemiology 2007, 28:140-145.
12. Carr K.A., Lybarger S.R., Anderson E.C., Janes B.K., Hanna P.C. The role of Bacillus anthracis germinant receptors in germination and virulence. Molecular Microbiology 2010, 75:365-375.
13. Giebel J.D., Carr K.A., Anderson E.C., Hanna P.C. The germination-specific lytic enzymes SleB, CwlJ1, and CwlJ2 each contribute to Bacillus anthracis spore germination and virulence. Journal of Bacteriology 2009, 191:5569-5576.
14. Kahm M., Hasenbrink G., Lichtenberg-Frate H., Ludwig J., Kschischo M. Grofit: fitting biological Growth Curves with R. Journal of Statistical Software 2010, 33:1-21.
15. R R: a language and environment for statistical computing 2009, R Foundation for Statistical Computing, Vienna, Austria.
16. Lyras D., O'Connor J.R., Howarth P.M., Sambol S.P., Carter G.P., Phumoonna T., et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009, 458:1176-1179.
17. Wilson K.H., Kennedy M.J., Fekety F.R. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. Journal of Clinical Microbiology 1982, 15:443-446.
18. Vohra P., Poxton I. Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. Microbiology 2011.
19. Kuehne S.A., Cartman S.T., Minton N.P. Both, toxin A and toxin B, are important in Clostridium difficile infection. Gut Microbes 2011, 2:252-255.
20. Vohra P., Poxton I.R. Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. Microbiology 2011, 157:1343-1353.
21. McDonald L.C., Killgore G.E., Thompson A., Owens R.C., Kazakova S.V., Sambol S.P., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. The New England Journal of Medicine 2005, 353:2433-2441.
22. Dineen S.S., Villapakkam A.C., Nordman J.T., Sonenshein A.L. Repression of Clostridium difficile toxin gene expression by CodY. Molecular Microbiology 2007, 66:206-219.
23. Ikeda D., Karasawa T., Yamakawa K., Tanaka R., Namiki M., Nakamura S. Effect of isoleucine on toxin production by Clostridium difficile in a defined medium. Zentralbl Bakteriol 1998, 287:375-386.
24. Karlsson S., Burman L.G., Akerlund T. Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology 1999, 145(Pt 7):1683-1693.
25. Karlsson S., Burman L.G., Akerlund T. Induction of toxins in Clostridium difficile is associated with dramatic changes of its metabolism. Microbiology 2008, 154:3430-3436.
26. Karlsson S., Lindberg A., Norin E., Burman L.G., Akerlund T. Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infection and Immunity 2000, 68:5881-5888.
27. Didelot X., Eyre D.W., Cule M., Ip C.L., Ansari M.A., Griffiths D., et al. Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biology 2012, 13:R118.